Fernando Avecilla

Polymer-Bound Oxidovanadium(IV) and Dioxidovanadium(V) Complexes As Catalysts for the Oxidative Desulfurization of Model Fuel Diesel

The Schiff base (Hfsal-dmen) derived from 3-formylsalicylic acid and N,N-dimethyl ethylenediamine has been covalently bonded to chloromethylated polystyrene to give the polymer-bound ligand, PS-Hfsal-dmen (I). Treatment of PS-Hfsal-dmen with [V(IV)O(acac)(2)] in the presence of MeOH gave the oxidovanadium(IV) complex PS-[V(IV)O(fsal-dmen)(MeO)] (1). On aerial oxidation in methanol, complex 1 was oxidized to PS-[V(V)O(2)(fsal-dmen)] (2). The corresponding neat complexes, [V(IV)O(sal-dmen)(acac)] (3) and [V(V)O(2)(sal-dmen)] (4) were similarly prepared. All these complexes are characterized by various spectroscopic techniques (IR, electronic, NMR, and electron paramagnetic resonance (EPR)) and thermal as well as field-emission scanning electron micrographs (FE-SEM) studies, and the molecular structures of 3 and 4 were determined by single crystal X-ray diffraction. The EPR spectrum of the polymer supported V(IV)O-complex 1 is characteristic of magnetically diluted V(IV)O-complexes, the resolved EPR pattern indicating that the V(IV)O-centers are well dispersed in the polymer matrix. A good (51)V NMR spectrum could also be measured with 4 suspended in dimethyl sulfoxide (DMSO), the chemical shift (-503 ppm) being compatible with a VO(2)(+)-center and a N,O binding set. The catalytic oxidative desulfurization of organosulfur compounds thiophene, dibenzothiophene, benzothiophene, and 2-methyl thiophene (model of fuel diesel) was carried out using complexes 1 and 2. The sulfur in model organosulfur compounds oxidizes to the corresponding sulfone in the presence of H(2)O(2). The systems 1 and 2 do not loose efficiency for sulfoxidation at least up to the third cycle of reaction, this indicating that they preserve their integrity under the conditions used. Plausible intermediates involved in these catalytic processes are established by UV-vis, EPR, (51)V NMR, and density functional theory (DFT) studies, and an outline of the mechanism is proposed. The (51)V NMR spectra recorded for solutions in methanol confirm that complex 4, on treatment with H(2)O(2), is able to generate peroxo-vanadium(V) complexes, including quite stable protonated peroxo-V(V)-complexes [V(V)O(O)(2)(sal-dmen-NH(+))]. The (51)V NMR and DFT data indicate that formation of the intermediate hydroxido-peroxo-V(V)-complex [V(V)(OH)(O(2))(sal-dmen)](+) does not occur, but instead protonated [V(V)O(O)(2)(sal-dmen-NH(+))] complexes form and are relevant for catalytic action.

Vanadium compounds as therapeutic agents: Some chemical and biochemical studies

The behaviour of three vanadium(V) systems, namely the pyridinone (V(V)-dmpp), the salicylaldehyde (V(V)-salDPA) and the pyrimidinone (V(V)-MHCPE) complexes, is studied in aqueous solutions, under aerobic and physiological conditions using (51)V NMR, EPR and UV-Visible (UV-Vis) spectroscopies. The speciations for the V(V)-dmpp and V(V)-salDPA have been previously reported. In this work, the system V(V)-MHCPE is studied by pH-potentiometry and (51)V NMR. The results indicate that, at pH ca. 7, the main species present are (V(V)O(2))L(2) and (V(V)O(2))LH(-1) (L=MHCPE(-)) and hydrolysis products, similar to those observed in aqueous solutions of V(V)-dmpp. The latter species is protonated as the pH decreases, originating (V(V)O(2))L and (V(V)O(2))LH. All the V(V)-species studied are stable in aqueous media with different compositions and at physiological pH, including the cell culture medium. The compounds were screened for their potential cytotoxic activity in two different cell lines. The toxic effects were found to be incubation time and concentration dependent and specific for each compound and type of cells. The HeLa tumor cells seem to be more sensitive to drug effects than the 3T3-L1 fibroblasts. According to the IC(50) values and the results on reversibility to drug effects, the V(V)-species resulting from the V(V)-MHCPE system show higher toxicity in the tumor cells than in non-tumor cells, which may indicate potential antitumor activity.

Vanadium-salen and -salan complexes: Characterization and application in oxygen-transfer reactions

Salen complexes are a versatile and standard system in oxidation catalysis. Their reduced derivatives, called salan, share their versatility but are still widely unexplored. We report the synthesis of a group of new vanadium-salen and -salan complexes, their characterization and application in the oxidation of simple organic molecules with H2O2. The ligands are derived from pyridoxal and chiral diamines (1,2-diaminocyclohexane and 1,2-diphenylethylenediamine) and were easily obtained in high yields. The VIV complexes were prepared and characterized in the solid state (Fourier transform infrared, FTIR, and magnetic properties) and in solution by spectroscopic techniques: UV–vis, circular dichroism (CD), electron paramagnetic resonance (EPR), and 51V NMR, which provide information on the coordination geometry. Single crystals suitable for X-ray diffraction studies were obtained from solutions containing the VIV-pyr(S,S-chan) complex: [VVO{pyr(S,S-chen)}]2(μ-O)2·2(CH3)2NCHO, where the ligand is the “half” Schiff base formed by pyridoxal and 1S,2S-diaminocyclohexane. The dinuclear species shows a OVV(μ-O)2VVO unit with tridentate ligands and two μ-oxo bridges. The VIV complexes of the salan-type ligands oxidize in organic solvents to a VV species, and the process was studied by spectroscopic techniques. The complexes were tested as catalysts in the oxidation of styrene, cyclohexene, and cumene with H2O2 as oxidant. Overall, the V-salan complexes show higher activity than the parent V-salen complexes and are an alternative ligand system for oxidation catalysis.

Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents

Several mixed ligand vanadium and copper complexes were synthesized containing 8-hydroxyquinoline (8HQ) and a ligand such as picolinato (pic(-)), dipicolinato (dipic(2-)) or a Schiff base. The complexes were characterized by spectroscopic techniques and by single-crystal X-ray diffraction in the case of [V(V)O(L-pheolnaph-im)(5-Cl-8HQ)] and [V(V)O(OMe)(8HQ)2], which evidenced the distorted octahedral geometry of the complexes. The electronic absorption data showed the presence of strong ligand to metal charge transfer bands, significant solvent effects, and methoxido species in methanol, which was further confirmed by (51)V-NMR spectroscopy. The structures of [Cu(II)(dipic)(8HQ)]Na and [V(IV)O(pic)(8HQ)] were confirmed by EPR spectroscopy, showing only one species in solution. The biological activity of the compounds was assessed through the minimal inhibitory concentration (MIC) of the compounds against Mycobacterium tuberculosis (Mtb) and the cytotoxic activity against the cisplatin sensitive/resistant ovarian cells A2780/A2780cisR and the non-tumorigenic HEK cells (IC50 values). Almost all tested vanadium complexes were very active against Mtb and the MICs were comparable to, or better than, the MICs of drugs, such as streptomycin. The activity of the complexes against the A2780 cell line was dependent on incubation time presenting IC50 values in the 3-14 μM (at 48 h) range. In these conditions, the complexes were significantly (*P<0.05-**P<0.001) more active than cisplatin (22 μM), in the A2780 cells and even surpassing its activity in the cisplatin-resistant cells A2780cisR (2.4-8 μM vs. 75.4; **P<0.001). In the non-tumorigenic HEK cells poor selectivity toward cancer cells for most of the complexes was observed, as well as for cisplatin.

Lead(II) complexes with macrocyclic receptors derived from 4,13-diaza-18-crown-6.

Pages 5883, 5884, 5886, 5888. Several reference numbers in the text are incorrect. Page 5883: The reference number 14 should be 20; 15 and 16 near the bottom of the left-hand column should be 21 and 22; 21 should be 27. Page 5884: The 28 should be 34; 29 should be 35. Page 5886: The 31 should be 37. Page 5888: The 33 should be 39. The version with corrected reference numbers is available electronically.

Polymer-bound oxidovanadium(IV) and dioxidovanadium(V) complexes: synthesis, characterization and catalytic application for the hydroamination of styrene and vinyl pyridine

The Schiff base (Hfsal-aepy) derived from 3-formylsalicylic acid and 2-(2-aminoethyl)pyridine has been covalently bonded to chloromethylated polystyrene cross-linked with 5% divinylbenzene (PS-Hfsal-aepy). Treatment of [V(IV)O(acac)(2)] with PS-Hfsal-aepy in dimethylformamide (DMF) gave the oxidovanadium(IV) complex PS-[V(IV)O(fsal-aepy)(acac)] 1, which on oxidation yielded the dioxidovanadium(V) PS-[V(V)O(2)(fsal-aepy)] 2 complex. The corresponding neat complexes, [V(IV)O(sal-aepy)(acac)] 3 and [V(V)O(2)(sal-aepy)] 4 have also been prepared. The compounds are characterized in solid state and in solution, namely by spectroscopic techniques (IR, UV-Vis, EPR, (1)H, (13)C and (51)V NMR), thermal as well as field-emission scanning electron micrograph (FE-SEM) studies. The crystal and molecular structure of [V(IV)O(sal-aepy)(acac)] was solved by single-crystal X-ray diffraction. It is a monomeric complex with the tridentate sal-aepy ligand bound equatorially and the two O-atoms of acac(-) bound at equatorial and axial positions. These complexes catalyze the hydroamination of styrene and vinyl pyridine with amines (aniline and diethylamine) yielding a mixture of two hydroaminated products in good yield. Amongst the two hydroaminated products, the anti-Markovnikov product is favored over the Markovnikov one. Plausible intermediates involved in these catalytic processes are established by UV-Vis, EPR and (51)V NMR studies, and an outline of the mechanism is proposed. The EPR spectrum of the polymer supported V(IV)O-complex 1 is characteristic of a magnetically diluted V(IV)O-complex, the resolved EPR pattern indicating that the oxidovanadium(IV) centers are well dispersed in the polymer matrix. Neat complexes exhibit lower conversion along with lower turnover frequency as compared to their polymer-anchored analogues. The polymer-anchored heterogeneous catalysts are free from leaching during catalytic action and are recyclable.

A novel VIVO–pyrimidinone complex: synthesis, solution speciation and human serum protein binding

The pyrimidinones mhcpe, 2-methyl-3H-5-hydroxy-6-carboxy-4-pyrimidinone ethyl ester (mhcpe, 1), 2,3-dimethyl-5-benzyloxy-6-carboxy-4-pyrimidinone ethyl ester (dbcpe, 2) and N-methyl-2,3-dimethyl-5-hydroxy-6-carboxyamido-4-pyrimidinone (N-MeHOPY, 3), are synthesized and their structures determined by single crystal X-ray diffraction. The acid-base properties of 1 are studied by potentiometric and spectrophotometric methods, the pK(a) values being 1.14 and 6.35. DFT calculations were carried out to determine the most stable structure for each of the H2L(+), HL and L(-) forms (HL = mhcpe) and assign the groups involved in the protonation-deprotonation processes. The mhcpe(-) ligand forms stable complexes with V(IV)O(2+) in the pH range 2 to 10, and potentiometry, EPR and UV-Vis techniques are used to identify and characterize the V(IV)O-mhcpe species formed. The results are consistent with the formation of V(IV)O, (V(IV)O)L, (V(IV)O)L2, (V(IV)O)2L2H(-2), (V(IV)O)L2H(-1), (V(IV)O)2L2H(-3), (V(IV)O)LH(-2) species and V(IV)O-hydrolysis products. Calculations indicate that the global binding ability of mhcpe towards V(IV)O(2+) is similar to that of maltol (Hmaltol = 3-hydroxy-2-methyl-4H-pyran-4-one) and lower than that of 1,2-dimethyl-3-hydroxy-4-pyridinone (Hdhp). The interaction of V(IV)O-complexes with human plasma proteins (transferrin and albumin) is studied by circular dichroism (CD), EPR and (51)V NMR spectroscopy. V(IV)O-mhcpe-protein ternary complexes are formed in both cases. The binding of V(IV)O(2+) to transferrin (hTF) in the presence of mhcpe involves mainly (V(IV)O)1(hTF)(mhcpe)1, (V(IV)O)2(hTF)(mhcpe)1 and (V(IV)O)2(hTF)(mhcpe)2 species, bound at the Fe(III) binding sites, and the corresponding conditional formation constants are determined. Under the conditions expected to prevail in human blood serum, CD data indicate that the V(IV)O-mhcpe complexes mainly bind to hTF; the formation of V(IV)O-hTF-mhcpe complexes occurs in the presence of Fe(III) as well, distinct EPR signals being clearly obtained for Fe(III)-hTF and to V(IV)O-hTF-mhcpe species. Thus this study indicates that transferrin plays the major role in the transport of V(IV)O-mhcpe complexes under blood plasma conditions in the form of ternary V(IV)-ligand-protein complexes.

Amino Alcohol-Derived Reduced Schiff Base VIVO and VV Compounds as Catalysts for Asymmetric Sulfoxidation of Thioanisole with Hydrogen Peroxide

We report the synthesis and characterization of several amino alcohol-derived reduced Schiff base ligands (AORSB) and the corresponding V(IV)O and V(V) complexes. Some of the related Schiff base variants (amino alcohol derived Schiff base = AOSB) were also prepared and characterized. With some exceptions, all compounds are formulated as dinuclear compounds {V(IV)O(L)}(2) in the solid state. Suitable crystals for X-ray diffraction were obtained for two of the AORSB compounds, as well as a rare X-ray structure of a chiral V(IV)O compound, which revealed a dinuclear {V(IV)O(AOSB)}(2) structure with a rather short V-V distance of 3.053(9) Å. Electron paramagnetic resonance (EPR), (51)V NMR, and density functional theory (DFT) studies were carried out to identify the intervenient species prior to and during catalytic reactions. The quantum-chemical DFT calculations were important to determine the more stable isomers in solution, to explain the EPR data, and to assign the (51)V NMR chemical shifts. The V(AORSB) and V(AOSB) complexes were tested as catalysts in the oxidation of thioanisole, with H(2)O(2) as the oxidant in organic solvents. In general, high conversions of sulfoxide were obtained. The V(AOSB) systems exhibited greater activity and enantioselectivity than their V(AORSB) counterparts. Computational and spectroscopic studies were carried out to assist in the understanding of the mechanistic aspects and the reasons behind such marked differences in activity and enantioselectivity. The quantum-chemical calculations are consistent with experimental data in the assessment of the differences in catalytic activity between V(AOSB) and V(AORSB) peroxido variants because the V(AORSB) peroxido transition states correspond to ca. 22 kJ/mol higher energy activation barriers than their V(AOSB) counterparts.

Copper complexes with bibracchial lariat ethers: from mono- to binuclear structures

Abstract Copper(II) complexes with a series of bibracchial lariat ethers are described. Independently of the nature of the counterion present (nitrate or perchlorate), the lariat ether N,N′-bis(2-aminobenzyl)-1,10-diaza-15-crown-5 (L1) always forms mononuclear complexes, whereas the lariat ethers N,N′-bis(2-aminobenzyl)-4,13-diaza-18-crown-6 (L2) and N,N′-bis(2-salicylaldiminobenzyl)-4,13-diaza-18-crown-6 (L3) only give binuclear compounds. The X-ray crystal structure of [CuL1](ClO4)2 shows a seven-coordinated copper(II) ion in a distorted (axially compressed) pentagonal-bipyramidal geometry. The X-ray crystal structure of [Cu2(L3-2H)](ClO4)2 confirms the binuclear nature of the compound with both metal ions having identical coordination environments and each one placed out of the crown hole but efficiently encapsulated by the corresponding pendant arm; each copper(II) ion is five-coordinated with an intermediate geometry between trigonal-bipyramidal and square-pyramidal (τ=0.40). The EPR spectra in frozen solution samples are in accordance with a stable coordinate pattern for the metal centre of ligand L1, yielding a rhombic distorted complex with axial compression in solution, in agreement with the X-ray crystal structure of [CuL1](ClO4)2. For the binuclear complexes of L2 and L3, the Cu(II) centres in solution can be distorted from their tetragonally elongated structures via interaction with ethanol and/or the nitrate counterion, leading to more than one species.

Electronic Properties of a Cytosine Decavanadate: Toward a Better Understanding of Chemical and Biological Properties of Decavanadates

We have synthesized and crystallized a cytosine-decavanadate compound, Na(3) [V(10)O(28)] (C(4)N(3)OH(5))(3)(C(4)N(3)OH(6))(3).10H(2)O, and its crystal structure has been determined from a single-crystal X-ray diffraction. A high resolution X-ray diffraction experiment at 210 K (in P1 space group phase) was carried out. The data were refined using a pseudo-atom multipole model to get the electron density and the electrostatic properties of the decavanadate-cytosine complex. Static deformation density maps and Atoms in Molecules (AIM) topological analysis were used for this purpose. To get insight into the reactivity of the decavanadate anion, we have determined the atomic net charges and the molecular electrostatic potential. Special attention was paid to the hydrogen bonding occurring in the solid state between the decavanadate anion and its environment. The comparison of the experimental electronic characteristics of the decavanadate anions to those found in literature reveals that this anion is a rigid entity conserving its intrinsic properties. This is of particular importance for the future investigations of the biological activities of the decavanadate anion.